LEX-WK-BTSCRQPHcrawled 2021-06-24 13:33Z
Getting Lost in the Thicket: AbbVie Wields Its Expansive Humira® Patent Portfolio Against Alvotech’s Adalimumab Biosimilar
Andrew J. Storaska · Biosimilars Law Bulletin · Published June 24, 2021
Work details
- author
- Andrew J. Storaska
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Intellectual Property
- published
- 2021-06-24
Citation
Andrew J. Storaska, Getting Lost in the Thicket: AbbVie Wields Its Expansive Humira® Patent Portfolio Against Alvotech’s Adalimumab Biosimilar, Biosimilars Law Bulletin (June 24, 2021) [The Library at LexBlog, LEX-WK-BTSCRQPH, lexpid.org/BTSCRQPH]